GenSight Biologics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 69%.

Top 14 shareholders own 40.7% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
17%	Sofinnova Partners SAS	13,260,067	€5.6m	86%	2.74%
6.73%	UPMC Enterprises	5,255,001	€2.2m	0%	no data
4.01%	Amiral Gestion	3,126,769	€1.3m	0%	0.09%
3.08%	Bpifrance Participations SA	2,399,681	€1.0m	0%	0.01%
2.86%	Artal Group S.A.	2,233,000	€936.7k	0%	0.03%
2.7%	3SBio Inc.	2,110,595	€885.4k	0%	no data
2.38%	Tangible Investment Management Ltd	1,854,856	€778.1k	0%	no data
1.68%	Abingworth LLP	1,308,521	€548.9k	0%	0.18%
0.077%	FMR LLC	59,807	€25.1k	0%	no data
0.067%	Gensight Biologics S.A,. Employee Stock Ownership Plan	52,500	€22.0k	0%	no data
0.045%	Saint Olive Gestion	35,000	€14.7k	0%	no data
0.038%	Gestys SA	30,000	€12.6k	0%	0.53%
0.028%	Alma Capital & Associés	22,030	€9.2k	0%	0.25%
0.013%	ACA - Asset Management Company & Associes	10,000	€4.2k	0%	0.03%